People

Chairman reMYND, President George Health Enterprises, Chairman ImevaX, serial entrepreneur

Managing Director LRD, the n°1 TTO in Europe

Managing Partner LSP-Health Economics Fund and founder VIB, a top 3 life science institute world-wide

Sr. Investment Manager PMV Lifesciences, the do and dare company shaping the future of the Flemish economy

Investment Manager, Federale Participatie- en Investeringsmaatschappij

Chairman Emeritus Janssen Pharmaceutica, Chairman VIB and numerous

Investment Director at Korys, a diversified, triple bottom-line family holding with life sciences one of its focus areas

Managing Director reMYND, former associate partner McKinsey

CSO Drug Discovery. Gerard obtained his PhD degree in 1996 at the Free University of Amsterdam where he pursued his research interests in the fields of Biochemistry and Molecular Biology by studying molecular mechanisms involved in controlling gene transcription.

He subsequently held research positions at the University of Vienna (Austria) and the University of Leuven (Belgium).

PhD, MBA, Chief Business Officer. Lode has over 25 years of experience in senior positions in both the biotechnology and pharmaceutical sector.

He began his career in Clinical Operations at UCB in Belgium and thereafter moved to the USA holding senior positions at UCB, BMS, Osiris Therapeutics and Aziyo Biologics. More recently, he founded 3RBiomed and Amynas.

Managing Director reMYND, former associate partner McKinsey

Professor at the Department of Psychiatry and Neurochemistry, University of Gothenburg.

Professor of Neurology and Psychiatry; Director Alzheimer Disease Research Center David Geffen School of Medicine at UCLA; member on the GRECC Advisory Committee.

Professor at the Institute of Neuroscience and Physiology and Head of the Department of Psychiatry and Neurochemistry, University of Gothenburg.